Canakinumab For The Treatment of Amyloidosis Secondary to Lung Cancer
Journal Title: Journal of European Internal Medicine Professionals (JEIMP) - Year 2023, Vol 1, Issue 3
Abstract
hakanozer724@gmail.com, yozturk29@gmail.com, dr.fyonet@gmail.com, i_baloglu@hotmail.com, ucmdkt@gmail.com
Authors and Affiliations
Hakan Özer, Yasin Öztürk, Fethi Yönet, İsmail Baloğlu, Kultiğin Türkmen
Keywords
Related Articles
- EP ID EP719143
- DOI https://doi.org/10.5281/zenodo.8134945
- Views 38
- Downloads 0
The Relationship Between the HALP Score and Gastric Cancer Prognosis
Background: Gastric adenocarcinoma is the fifth most common malignancy worldwide and the third leading cause of cancer-related deaths. As most patients are diagnosed in the advanced stage of the disease, the prognosis is...
Neuromuscular Dysfunction and Electrophysiological Findings in Patients With Hypothyroidism and Hyperthyroidism
Background: We aimed to determine the frequency of neuropathy and myopathy in newly diagnosed hypothyroid and hyperthyroid patients and to investigate the correlation between serum creatine kinase (CK) concentration and...
Successfully Completed Twin Pregnancy of a Peritoneal Dialysis Patient
This is a letter to the editors. An abstract is not available.
The Other Side of The Coin in Assisted Peritoneal Dialysis
Background: Assisted peritoneal dialysis (aPD) has long been used worldwide to treat elderly and frail patients with end-stage renal disease. In developed countries, aPD is provided by health professionals, while in dev...
Canakinumab For The Treatment of Amyloidosis Secondary to Lung Cancer
hakanozer724@gmail.com, yozturk29@gmail.com, dr.fyonet@gmail.com, i_baloglu@hotmail.com, ucmdkt@gmail.com